SCHEMBL7046151

SCHEMBL7046151

CCCOc1cc(N(N)C(=O)OC(C)(C)C)ccc1C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 2/20 0.36
THRB P10828 2/20 0.36
RXRA P19793 3/20 0.36
NR1H2 P55055 2/20 0.36
NR1H3 Q13133 2/20 0.36
S1PR1 P21453 3/20 0.35
MAPT P10636 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TRPV1 Q8NER1 1/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33
PSENEN Q9NZ42 1/20 0.33
CACNA1G O43497 1/20 0.33
CACNA1B Q00975 1/20 0.33
CACNA1C Q13936 1/20 0.33
KEAP1 Q14145 1/20 0.33
NFE2L2 Q16236 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6623841 0.88 RXRA (0.37) THRBRXRANR1H2NR1H3S1PR1
SCHEMBL6879931 0.84 MRGPRX4 (0.37) RXRANR1H2NR1H3MAPTCACNA1G
SCHEMBL6879592 0.82 NR1H2 (0.39) THRBRXRANR1H2NR1H3PSEN1
SCHEMBL6877992 0.81 POLQ (0.37) THRBRXRANR1H2NR1H3S1PR1
SCHEMBL6879948 0.79 KIF11 (0.40) RXRANR1H2NR1H3CACNA1GCACNA1B
SCHEMBL17336857 0.79 LMNA (0.36) RXRANR1H2NR1H3CACNA1GCACNA1B
SCHEMBL6878671 0.76 LMNA (0.36) RXRANR1H2NR1H3CACNA1GCACNA1B
SCHEMBL6881686 0.75 KDR (0.41) S1PR1MAPTLMNA
SCHEMBL6624271 0.74 AAK1 (0.37) THRBRXRANR1H2NR1H3CACNA1G
SCHEMBL2529611 0.72 MT-CO2 (0.42) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474416-A1 DIHYDROBENZODIAZEPIN-2-ONE-DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2004-11-10 EP disclosed
WO-2003066623-A1 DIHYDROBENZODIAZEPIN-2-ONE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2003-08-14 WO disclosed